author-photo

Kimberly A. Kraynyak

University of Pennsylvania

46

Papers

1073

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (12)
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Association of putative activated CD8+ T cells with modulation of rising serum PSA levels in biochemically relapsed prostate cancer patients using immunotherapy targeting prostate tumor-associated antigens: a Phase 1 study

2020 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (3)
INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma (GBM): Interim results.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
LTBK-01. INO-5401 AND INO-9012 DELIVERED INTRAMUSCULARLY (IM) WITH ELECTROPORATION (EP) IN COMBINATION WITH CEMIPLIMAB (REGN2810) IN NEWLY DIAGNOSED GLIOBLASTOMA

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
P858 An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM)

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Abstract CT126: A synthetic DNA plasmid encoding HPV6 E6 and E7 proteins in patients with HPV6-associated aerodigestive lesions

2020 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.

2020 EClinicalMedicine
Show All
- Source
- Cite
- Save
Citations (90)
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers

2019 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (48)
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines

2019 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (16)